“Sanjay has both the strong strategic regulatory skills and the proven record of success required to help scPharmaceuticals toward the goal of delivering products to patients,” John Tucker, CEO, scPharmaceuticals
MILFORD, Mass. (PRWEB) December 15, 2017
Executive search firm Prestige Scientific is pleased to announce the successful placement of Sanjay Sehgal as SVP Regulatory Affairs, QA, and Compliance of scPharmaceuticals, a clinical-stage pharmaceutical company focused on developing and commercializing products that, through its proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. Managing Partner and Co-Founder Stephen Provost, CPC led the search.
“Sanjay is a strategic thinker and a very strong leader with outstanding people skills and will be critical to helping scPharmaceuticals achieve its long-term growth plan,” said Mr. Provost. "Mr. Sehgal is a seasoned regulatory executive with a deep background covering every major facet required in a SVP Regulatory, Quality, and Compliance role. He has extensive experience in regulatory approvals, has been involved in numerous health agency interactions, development of advertising/ promotion materials, adverse event reporting, managed pre-approval inspections, and is steeped in strategy and execution," said Provost.
He was previously with Aprecia, where most recently he was the VP Regulatory Affairs, Clinical Affairs, and Conformance. Before that, Mr. Sehgal was Head of Regulatory Affairs of Sucampo Pharmaceuticals where he led regulatory strategy for both clinical and commercial products. He was also Chief Regulatory Officer of NuPathe responsible for negotiating the approval of a 505(b)(2) drug device combination product.
“Sanjay has both the strong strategic regulatory skills and the proven record of success required to help scPharmaceuticals toward the goal of delivering products to patients,” said John Tucker, scPharmaceutical’s President and CEO. “Sanjay’s experience gaining regulatory approvals with 505(b)(2) combination products, as well as leading highly productive and collaborative teams, will be enormously beneficial to scPharmaceuticals as we grow from a research and development company to a commercial-stage organization.”
Prestige Scientific, a member of the Sanford Rose Associates network, provides executive search services to clients and candidates servicing the pharmaceutical and biotechnology industries. Sanford Rose has over 70 offices worldwide with locations in North America, Latin America and Asia. Prestige Scientific has successfully conducted numerous searches for CxO, Senior Vice Presidents, Vice Presidents, General Managers, Global Heads, and other executive management roles. Prestige partners with privately held through large cap companies in development through commercialization stages.
For more information please contact Stephen Provost, Managing Partner sprovost(at)prestigescientific(dot)com.
409 Fortune Blvd Suite 3
Milford, MA 01757